US News & World Report
The ABCs of COPD
Despite falling death rates, COPD is third leading cause of death in the U.S., according to the Centers for Disease Control and Prevention.
Mon Aug 25, 2014
NYU Langone Medical Center to Lead Research to Develop Breath Test...
NYU Langone Medical Center will lead a new clinical initiative -- funded by a $225,000 grant from The National Institutes of Health -- to determine a breath test's effectivness to identify volatile organic compounds in human breath that are biomarkers of chronic obstrutive pulmonary disease .
Thu Aug 21, 2014
Theravance Biopharma: Neglected Spinoff Targeting A Huge Underserved Market
Theravance is probably a familiar name to many of you. The pharmaceutical company has received extensive coverage on Seeking Alpha over the years.
Fri Aug 15, 2014
Lung Cancer Risk Increases For Patients Previously Diagnosed With A Respiratory Disease
Patients who have previously been diagnosed with a chronic respiratory disease, like bronchitis, are at an increased risk for lung cancer, according to a large study analysis conducted by the American Thoracic Society.
Wed Aug 13, 2014
Findings from Tohoku University Yields New Data on Immunologic...
In search of a treatment target molecule, which is able to regenerate collapsed alveoli, we sought to identify a factor that induces differentiation in human alveolar epithelial stem cells using all-trans retinoic acid , whose alveolar repair capacity has been reported in animal experiments."
Umeclidinium/vilanterol outperforms monotherapies in COPD
A combination of umeclidinium and vilanterol is more effective than each drug as monotherapy for the treatment of chronic obstructive pulmonary disease , research indicates.
Tue Aug 12, 2014
The Motley Fool
3 Value Stocks Worth Buying
Just as we often examine companies that may be rising past their fair values, we can also find companies trading at what may be bargain prices.
Mon Aug 11, 2014
Aquinox Pharmaceuticals' (AQXP) CEO David Main on Q2 2014 Results - Earnings Call Transcript
Good afternoon, ladies and gentlemen. Thank you for standing by and welcome to the Aquinox Pharmaceuticals Second Quarter 2014 Conference Call.
Sun Aug 10, 2014
Why people with COPD may be putting themselves at unnecessary risk
Imagine experiencing shortness of breath, wheezing, and a cough so severe it requires you to visit the emergency room.
Fri Aug 08, 2014
Miner due Black Lung benefits despite smoking history: Court
A former coal mine worker with chronic obstructive pulmonary disease should receive benefits under the federal Black Lung Benefits Act despite his nearly 40-year history of cigarette smoking, the 6th U.S. Circuit Court of Appeals ruled has ruled.
The Press On-Line
Christchurch patients wanted for health study
CLEARING THE AIR: Roger Dennis, of Sensing City, with sensors measuring particulate matter and Smartinhaler, a sensor-equipted inhaler that sends information when it is used by the patient.
Wed Aug 06, 2014
Effectiveness of the Assessment of Burden of Chronic Obstructive...
Effectiveness of the Assessment of Burden of Chronic Obstructive Pulmonary Disease tool: study protocol of a cluster randomised trial in primary and secondary care Annerika HM Slok , Johannes CCM in t Veen , Niels H Chavannes , Thys van der Molen , Maureen PMH Molken , Huib AM Kerstjens , Guus M Asijee , Philippe L Salome , Sebastiaan Holverda , ... (more)
Actavis welcomes AZ in boosting its LAMA/LABA
Actavis says it is excited to partner with AstraZeneca over its long-acting muscarinic antagonist/beta-agonist fixed dose combination respiratory drug following the latter's acquisition of Almirall.
Mon Aug 04, 2014
AstraZeneca coughs up $875m for Almirall to support asthma/COPD pipeline
The total price of the Barcelona, Spain-headquartered pharma firm could reach $1.22bn following development, launch, and sales-related milestones, but its respiratory assets will strengthen the Pharma Giant's inhaled asthma and COPD portfolio, adding to the inhaler and particle technology acquired in the $1.5bn Pearl Therapeutics transaction in ... (more)
Sat Aug 02, 2014
Big News Network.com
AstraZeneca agrees to strategic transaction with Almirall in respiratory disease
Our eNewspaper network was founded in 2002 to provide stand-alone digital news sites tailored for the most searched-for locations for news.
Thu Jul 31, 2014
Striverdi Respimat found to help COPD sufferers breathe easier
In an effort to help patients with Chronic Obstructive Pulmonary Disease breathe easier, the FDA has approved the use of Striverdi Respimat inhalation spray to relax the muscles around the airways in the lungs stay and prevent symptoms.
FDA Approves New COPD Treatment
The FDA has approved olodaterol inhalation spray as a once-daily maintenance therapy for chronic obstructive pulmonary disease.
Boehringer Ingelheim Ups The Ante In Treating Lung Disorders
Respiratory Leader Boehringer Ingelheim Ups The Ante In "Real-World" Trial Design - And Pushes The Envelope In Treating Lung Disorders.
Wed Jul 30, 2014
The Financial Costs Of COPD Estimated To Be $36...
Image Caption: COPD is one of the many chronic lower respiratory diseases which are currently the number three leading cause of death of Americans.